The Single-Cell Analysis segment focuses on providing tools and technologies that enable researchers to study individual cells and their unique characteristics. This involves the development and manufacturing of microfluidic devices, instruments, and reagents for isolating, processing, and analyzing single cells. Key technologies include microfluidics, mass cytometry (CyTOF), and imaging mass cytometry (IMC). These tools are used in various research areas, including immunology, oncology, and stem cell biology, to understand cellular heterogeneity, identify rare cell populations, and discover new biomarkers. The segment's products help researchers gain deeper insights into disease mechanisms and develop more targeted therapies. Future opportunities include expanding the application of single-cell analysis in clinical diagnostics and personalized medicine.

The Genomics and Proteomics segment is dedicated to developing and commercializing technologies for high-throughput analysis of genes and proteins. This includes instruments, consumables, and software solutions for applications such as gene expression profiling, genotyping, and protein quantification. Key technologies include integrated fluidic circuits (IFCs) and real-time PCR systems. These tools are used in various research areas, including drug discovery, biomarker identification, and personalized medicine. The segment's products help researchers accelerate their research and development efforts and improve the accuracy and reliability of their results. Future opportunities include expanding the application of genomics and proteomics in clinical diagnostics and precision medicine.